Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Regulatory Considerations for Hemodiafiltration in the United States.

Ward RA, Vienken J, Silverstein DM, Ash S, Canaud B; Kidney Health Initiative HDF Workgroup.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1444-1449. doi: 10.2215/CJN.12641117. Epub 2018 Mar 6.

2.

Hemodiafiltration to Address Unmet Medical Needs ESKD Patients.

Canaud B, Vienken J, Ash S, Ward RA; Kidney Health Initiative HDF Workgroup.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1435-1443. doi: 10.2215/CJN.12631117. Epub 2018 Mar 6.

3.

Dialog Across Boundaries: A Tribute to Dieter Falkenhagen.

Vienken J.

Artif Organs. 2015 Nov;39(11):923-5. doi: 10.1111/aor.12640. No abstract available.

PMID:
26489867
4.

Agreement between 24-hour salt ingestion and sodium excretion in a controlled environment.

Lerchl K, Rakova N, Dahlmann A, Rauh M, Goller U, Basner M, Dinges DF, Beck L, Agureev A, Larina I, Baranov V, Morukov B, Eckardt KU, Vassilieva G, Wabel P, Vienken J, Kirsch K, Johannes B, Krannich A, Luft FC, Titze J.

Hypertension. 2015 Oct;66(4):850-7. doi: 10.1161/HYPERTENSIONAHA.115.05851. Epub 2015 Aug 10.

5.

Jan Maria Wojcicki (1946-2013): scientist, organizer, friend.

Ladyzynski P, Stegmayr B, Vienken J, Malchesky PS.

Artif Organs. 2014 Apr;38(4):271-3. doi: 10.1111/aor.12301. No abstract available.

PMID:
24702313
6.

In memoriam Jan Maria Wojcicki (1946 - 2013).

Ladyzynski P, Stegmayr B, Vienken J.

Int J Artif Organs. 2014 Jan;37(1):96-7. doi: 10.5301/IJAO.2014.11802. Epub 2014 Jan 27. No abstract available.

PMID:
24634339
7.

20 years since the establishment of the BANTAO association (Balkan Cities Association of Nephrology, Dialysis, Transplantation and Artificial Organs).

Polenakovic M, Nenov D, Basci A, Djukanovic L, Tsakiris D, Nesic V, Schiller A, Spasovski G, Klinkmann H, Vienken J, Falkenhagen D, Ivanovich P.

Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2013;34(2):181-213.

PMID:
24280893
8.

Bioinspired multiple-interaction model revealed in adsorption of low-density lipoprotein to surface containing saccharide and alkanesulfonate.

Li J, Huang XJ, Vienken J, Xu ZK, Groth T.

Langmuir. 2013 Jul 2;29(26):8363-9. doi: 10.1021/la401464a. Epub 2013 Jun 21.

PMID:
23742692
9.

Long-term space flight simulation reveals infradian rhythmicity in human Na(+) balance.

Rakova N, Jüttner K, Dahlmann A, Schröder A, Linz P, Kopp C, Rauh M, Goller U, Beck L, Agureev A, Vassilieva G, Lenkova L, Johannes B, Wabel P, Moissl U, Vienken J, Gerzer R, Eckardt KU, Müller DN, Kirsch K, Morukov B, Luft FC, Titze J.

Cell Metab. 2013 Jan 8;17(1):125-31. doi: 10.1016/j.cmet.2012.11.013.

10.

Biomaterials in medical devices: an interview with Jörg Vienken of Fresenius Medical Care, Germany.

Vienken J.

Biotechnol J. 2012 Jun;7(6):702-3. doi: 10.1002/biot.201200147.

PMID:
22653825
11.

Welcome to the 4th joint European Society for Artificial Organs-international Federation for Artificial Organs Congress.

Vienken J.

Artif Organs. 2011 Sep;35(9):839. doi: 10.1111/j.1525-1594.2011.01333.x. No abstract available.

PMID:
21906092
12.

Welcome to the European Society for Artificial Organs-International Federation for Artificial Organs joint congress in Porto, Portugal.

Reis RL, Vienken J, Schima H, Wagner W, Tominaga R.

Artif Organs. 2011 Sep;35(9):838-9. doi: 10.1111/j.1525-1594.2011.01332.x. No abstract available.

PMID:
21906091
13.

Contribution of polysulfone membranes to the success of convective dialysis therapies.

Bowry SK, Gatti E, Vienken J.

Contrib Nephrol. 2011;173:110-118. doi: 10.1159/000328960. Epub 2011 Aug 8. Review.

PMID:
21865783
14.

Covalent heparin modification of a polysulfone flat sheet membrane for selective removal of low-density lipoproteins: a simple and versatile method.

Li J, Huang XJ, Ji J, Lan P, Vienken J, Groth T, Xu ZK.

Macromol Biosci. 2011 Sep 9;11(9):1218-26. doi: 10.1002/mabi.201100071. Epub 2011 Jul 4.

PMID:
21728235
15.

Why are so few degradable polymeric biomaterials currently established in clinical applications?

Lendlein A, Neffe AT, Pierce BF, Vienken J.

Int J Artif Organs. 2011 Feb;34(2):71-5. No abstract available.

PMID:
21374576
16.

Blood compatibility and permeability of heparin-modified polysulfone as potential membrane for simultaneous hemodialysis and LDL removal.

Huang XJ, Guduru D, Xu ZK, Vienken J, Groth T.

Macromol Biosci. 2011 Jan 10;11(1):131-40. doi: 10.1002/mabi.201000278. Epub 2010 Sep 28.

PMID:
20878965
17.

"Artificial Organs Today: From in vitro assessment to human therapies". Foreword.

Polenakovic M, Sikole A, Vienken J.

Prilozi. 2008 Dec;29(2):9-11. No abstract available.

PMID:
19835023
19.

[Kidney and liver support therapies: state-of-the-art methods].

Roy T, Vienken J, Wabel P.

Biomed Tech (Berl). 2009 Oct;54(5):245-54. doi: 10.1515/BMT.2009.035. Review. German.

PMID:
19807288
20.

Immobilization of heparin on polysulfone surface for selective adsorption of low-density lipoprotein (LDL).

Huang XJ, Guduru D, Xu ZK, Vienken J, Groth T.

Acta Biomater. 2010 Mar;6(3):1099-106. doi: 10.1016/j.actbio.2009.08.039. Epub 2009 Sep 3.

PMID:
19733266
21.

Should dialysis modalities be designed to remove specific uremic toxins?

Baurmeister U, Vienken J, Ward RA.

Semin Dial. 2009 Jul-Aug;22(4):454-7. doi: 10.1111/j.1525-139X.2009.00599.x. Review.

PMID:
19709001
22.

'Bioengineering for life': a tribute to Willem Johan Kolff.

Vienken J.

Nephrol Dial Transplant. 2009 Aug;24(8):2299-301. No abstract available.

PMID:
19623721
23.

Salt, the neglected silent killer.

Shaldon S, Vienken J.

Semin Dial. 2009 May-Jun;22(3):264-6. doi: 10.1111/j.1525-139X.2009.00606.x. Review.

PMID:
19573007
24.

Beyond the current paradigm: recent advances in the understanding of sodium handling. An introduction.

Shaldon S, Vienken J.

Semin Dial. 2009 May-Jun;22(3):252. doi: 10.1111/j.1525-139X.2009.00605.x. Review. No abstract available.

PMID:
19573003
25.

"Inventions can't wait": a tribute to Willem Johan Kolff.

Vienken J, Klinkmann H, Rakhorst G.

Int J Artif Organs. 2009 Apr;32(4):191-8. No abstract available.

PMID:
19569026
27.

Health is wealth! Is wealth health?

Klinkmann H, Vienken J.

Prilozi. 2008 Dec;29(2):13-23.

PMID:
19259035
28.

Score model for the evaluation of dialysis membrane hemocompatibility.

Erlenkötter A, Endres P, Nederlof B, Hornig C, Vienken J.

Artif Organs. 2008 Dec;32(12):962-9. doi: 10.1111/j.1525-1594.2008.00657.x.

PMID:
19133025
29.

MDT's five-minute interview.

Vienken J.

Med Device Technol. 2008 May-Jun;19(3):6. No abstract available.

PMID:
18557401
30.

One of the pioneers of dialysis membranes, Werner Henne, passes away.

Vienken J.

Artif Organs. 2008 Jun;32(6):423-4. doi: 10.1111/j.1525-1594.2008.00590.x. No abstract available.

PMID:
18522552
31.

The long forgotten salt factor and the benefits of using a 5-g-salt-restricted diet in all ESRD patients.

Shaldon S, Vienken J.

Nephrol Dial Transplant. 2008 Jul;23(7):2118-20. doi: 10.1093/ndt/gfn175. Epub 2008 Apr 10. No abstract available.

PMID:
18403433
32.

The need for a systems approach in biomaterials testing.

Vienken J.

Med Device Technol. 2007 Sep;18(5):12-4, 16-7.

PMID:
17939365
33.

Homocysteine exerts genotoxic and antioxidative effects in vitro.

Fink K, Brink A, Vienken J, Heidland A, Stopper H.

Toxicol In Vitro. 2007 Dec;21(8):1402-8. Epub 2007 May 18.

PMID:
17590309
34.

How can liver toxins be removed? Filtration and adsorption with the Prometheus system.

Vienken J, Christmann H.

Ther Apher Dial. 2006 Apr;10(2):125-31. Review.

PMID:
16684213
35.

Does an alteration of dialyzer design and geometry affect biocompatibility parameters?

Opatrný K Jr, Krouzzecký A, Polanská K, Mares J, Tomsů M, Bowry SK, Vienken J.

Hemodial Int. 2006 Apr;10(2):201-8.

PMID:
16623675
36.

Relation between different treatment modalities and genomic damage of end-stage renal failure patients.

Kobras K, Schupp N, Nehrlich K, Adelhardt M, Bahner U, Vienken J, Heidland A, Sebekova K, Stopper H.

Kidney Blood Press Res. 2006;29(1):10-7. Epub 2006 Mar 28.

37.

Effect of different hemodialysis regimens on genomic damage in end-stage renal failure.

Schupp N, Stopper H, Rutkowski P, Kobras K, Nebel M, Bahner U, Vienken J, Heidland A.

Semin Nephrol. 2006 Jan;26(1):28-32. Review.

PMID:
16412822
38.

Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation.

Gotloib L, Fudin R, Yakubovich M, Vienken J.

Nephrol Dial Transplant. 2005 Jul;20 Suppl 7:vii32-6.

PMID:
16024831
39.

Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis.

Fragedaki E, Nebel M, Schupp N, Sebekova K, Völkel W, Klassen A, Pischetsrieder M, Frischmann M, Niwa T, Vienken J, Heidland A, Stopper H.

Nephrol Dial Transplant. 2005 Sep;20(9):1936-43. Epub 2005 May 26.

PMID:
15919695
40.

Effects of hemodialysis, dialyser type and iron infusion on oxidative stress in uremic patients.

Müller C, Eisenbrand G, Gradinger M, Rath T, Albert FW, Vienken J, Singh R, Farmer PB, Stockis JP, Janzowski C.

Free Radic Res. 2004 Oct;38(10):1093-100.

PMID:
15512797
41.

Prediction of cardiovascular risk in hemodialysis patients by data mining.

Pfaff M, Weller K, Woetzel D, Guthke R, Schroeder K, Stein G, Pohlmeier R, Vienken J.

Methods Inf Med. 2004;43(1):106-13.

PMID:
15026849
42.

Increased expression of p16(INK4a) and p27(Kip1) cyclin-dependent kinase inhibitor genes in aging human kidney and chronic allograft nephropathy.

Chkhotua AB, Gabusi E, Altimari A, D'Errico A, Yakubovich M, Vienken J, Stefoni S, Chieco P, Yussim A, Grigioni WF.

Am J Kidney Dis. 2003 Jun;41(6):1303-13.

PMID:
12776284
43.

Increased expression of p21 (WAF1/CIP1) cyclin-dependent kinase (CDK) inhibitor gene in chronic allograft nephropathy correlates with the number of acute rejection episodes.

Chkhotua AB, Altimari A, Gabusi E, D'Errico A, Stefoni S, Chieco P, Yakubovich M, Vienken J, Yussim A, Grigioni WF.

Transpl Int. 2003 Aug;16(8):502-6. Epub 2003 Apr 29.

PMID:
12719801
44.

Increased expression of P21((WAF1/CIP1)) CDKI gene in chronic allograft nephropathy correlating with the number of acute rejection episodes.

Chkhotua AB, Altimari A, Gabusi E, D'Errico A, Yakubovich M, Vienken J, Stefoni S, Chieco P, Yussim A, Grigioni WF.

Transplant Proc. 2003 Mar;35(2):655-8. No abstract available.

PMID:
12644083
45.

Extracorporeal liver support: porcine or human cell based systems?

Gerlach JC, Zeilinger K, Sauer IM, Mieder T, Naumann G, Grünwald A, Pless G, Holland G, Mas A, Vienken J, Neuhaus P.

Int J Artif Organs. 2002 Oct;25(10):1013-8.

PMID:
12456044
46.

Verification of the chemical composition and specifications of haemodialysis membranes by NMR and GPC-FTIR-coupled spectroscopy.

Gores F, Montag P, Schall C, Vienken J, Bowry SK.

Biomaterials. 2002 Aug;23(15):3131-40. Erratum in: Biomaterials. 2003 Apr;24(8):1525..

PMID:
12102184
47.

Polymers in nephrology. Characteristics and needs.

Vienken J.

Int J Artif Organs. 2002 May;25(5):470-9. Review.

PMID:
12074346
48.

Validation of a two-pool model for the kinetics of beta2-microglobulin.

Stiller S, Xu XQ, Gruner N, Vienken J, Mann H.

Int J Artif Organs. 2002 May;25(5):411-20.

PMID:
12074339
49.

Plasma levels of advanced glycation end products during haemodialysis, haemodiafiltration and haemofiltration: potential importance of dialysate quality.

Gerdemann A, Wagner Z, Solf A, Bahner U, Heidland A, Vienken J, Schinzel R.

Nephrol Dial Transplant. 2002 Jun;17(6):1045-9.

PMID:
12032195
50.

In vitro evaluation of the hydraulic permeability of polysulfone dialysers.

Eloot S, De Wachter D, Vienken J, Pohlmeier R, Verdonck P.

Int J Artif Organs. 2002 Mar;25(3):210-6.

PMID:
11999193

Supplemental Content

Loading ...
Support Center